← Back to Clinical Trials
Recruiting NCT06966518

NCT06966518 Intraoperative Combination of Ketamine and Magnesium Sulfate Infusions on Postoperative Analgesia in Open Rhinoplasty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06966518
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Intraoperative
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-05-12
Primary Completion 2025-10-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Ketamine and Magnesium SulfateSaline 0.9%

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-05-12 with a primary completion date of 2025-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to evaluate the effectiveness of intraoperative combination of ketamine and magnesium sulfate infusions on postoperative analgesia in patients undergoing open rhinoplasty.

Eligibility Criteria

Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I - II. * Scheduled for rhinoplasty under general anesthesia. Exclusion Criteria: * Receiving analgesic or any medications since 48 hours before the surgery. * Drug addiction. * Cardiovascular disease. * Respiratory disease, renal, liver, metabolic and neurological disease. * Pregnancy or breast feeding. * Asthma.

Contact & Investigator

Central Contact

Sarah A Afifi, MD

✉ Sarah606060@gmail.com

📞 0501035864

Frequently Asked Questions

Who can join the NCT06966518 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Intraoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06966518 currently recruiting?

Yes, NCT06966518 is actively recruiting participants. Contact the research team at Sarah606060@gmail.com for enrollment information.

Where is the NCT06966518 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06966518 clinical trial?

NCT06966518 is sponsored by Ain Shams University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology